Skip to main content

Table 3 Comparison of Uno’s C-statistics for each endpoint

From: Usefulness of glycated albumin as a predictor of mortality in chronic hemodialysis patients with diabetes: a multi-center, prospective cohort study

Model 1Original factorsOriginal factors + GAOriginal factors + HbA1c
All-causes0.718 (0.024)0.718 (0.020)0.720 (0.019)
p value 0.9630.655
p value✻✻  0.638
ASCVD0.806 (0.049)0.824 (0.055)0.810 (0.053)
p value 0.2390.714
p value✻✻  0.141
Non-ASCVD0.728 (0.026)0.730 (0.025)0.735 (0.022)
p value 0.6220.264
p value✻✻  0.279
Model 2Original factorsOriginal factors + GAOriginal factors + HbA1c
All-causes0.718 (0.019)0.718 (0.018)0.718 (0.023)
p value 0.8710.993
p value✻✻  0.921
ASCVD0.806 (0.061)0.817 (0.049)0.809 (0.073)
p value 0.4640.794
p value✻✻  0.430
Non-ASCVD0.728 (0.027)0.729 (0.023)0.731 (0.026)
p value 0.7290.480
p value✻✻  0.595
  1. Model 1, in which the hazard ratios were estimated using baseline GA or HbA1c values; and model 2, which used mean values of GA or HbA1c during the follow-up period
  2. ASCVD atherosclerotic cardiovascular disease, GA glycated albumin, HbA1c hemoglobin A1c
  3. vs Uno’s C-statistics of original factors; ✻✻vs Uno’s C-statistics of original factors plus GA